Brief: Vaxcyte Publishes Positive Vax-31 Phase 1/2 Adult Study Results In The Lancet Infectious Diseases
18/03/2026 23:36
March 18 (Reuters) - Vaxcyte Inc PCVX.O: VAXCYTE INC - PUBLISHES POSITIVE VAX-31 PHASE 1/2 ADULT STUDY RESULTS IN THE LANCET INFECTIOUS DISEASES VAXCYTE INC - STUDY RESULTS SHOWED THAT VAX-31 WAS OBSERVED TO BE WELL TOLERATED Source text: ID:nGNX5sWrDK Further company coverage: PCVX.O ((Reuters.Briefs@thomsonreuters.com;))